Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

BACKGROUND: Recently, immunotherapy (IO) has shown striking survival improvement in unresectable stage III non-small cell lung cancer (NSCLC). However, the role of chemo-radiotherapy (CRT) for improvement in outcomes should not be disregarded. This study aimed to compare the treatment patterns and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Shijie, Wang, Ruiyang, Wang, Fei, Wu, Meng, Chen, Dawei, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248867/
https://www.ncbi.nlm.nih.gov/pubmed/35785183
http://dx.doi.org/10.3389/fonc.2022.874022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248867/
https://www.ncbi.nlm.nih.gov/pubmed/35785183
http://dx.doi.org/10.3389/fonc.2022.874022

Ejemplares similares